Search

everythinglearnresearchcommunity

for

Search:↓

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

Women are more likely to have long-term post-COVID symptoms than men.

Older men and those with a history of skin cancer have a higher risk of getting skin cancer again.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.